Krensavage Asset Management

Krensavage Asset Management as of Sept. 30, 2015

Portfolio Holdings for Krensavage Asset Management

Krensavage Asset Management holds 23 positions in its portfolio as reported in the September 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Enanta Pharmaceuticals (ENTA) 9.6 $26M 730k 36.14
United Therapeutics Corporation (UTHR) 9.5 $26M 200k 131.24
Baxalta Incorporated 8.2 $23M 722k 31.51
Teva Pharmaceutical Industries (TEVA) 7.6 $21M 373k 56.46
Orthofix International Nv Com Stk 7.5 $21M 610k 33.75
Impax Laboratories 6.8 $19M 531k 35.22
Indivior 5.5 $15M 4.5M 3.43
Halyard Health 5.5 $15M 536k 28.44
Amgen 5.2 $14M 104k 138.32
CONMED Corporation (CNMD) 4.7 $13M 275k 47.74
Merck & Co (MRK) 4.5 $12M 250k 49.39
Hill-Rom Holdings 3.9 $11M 206k 51.99
Sucampo Pharmaceuticals 3.8 $11M 528k 19.87
RTI Biologics 3.8 $10M 1.8M 5.68
DepoMed 2.6 $7.1M 375k 18.85
Allergan 2.4 $6.6M 24k 271.82
Spectrum Pharmaceuticals 2.3 $6.4M 1.1M 5.98
Invacare Corporation 2.1 $5.8M 402k 14.47
Biota Pharmaceuticals Inc cs 1.8 $5.1M 2.6M 1.98
Juniper Pharmaceuticals Incorporated 1.2 $3.3M 280k 11.78
Digirad Corporation 0.6 $1.7M 458k 3.74
Furiex Pharmaceuticals 0.5 $1.4M 146k 9.77
Theravance 0.5 $1.3M 176k 7.18